BMC Cancer

Table 4 Paired t-tests to evaluate responsiveness to neoadjuvant chemotherapy

From: A new relative tumor sizing method in epi-metaphyseal osteosarcoma

		Total		Survival				Metastasis
		Total		5-year survival		Death		Free		Positive
		Mean±SD	P	Mean±SD	P	Mean±SD	P	Mean±SD	P	Mean±SD	P
ATL (mm)	BC	116.46	0.850	112.51	0.679	126.52	0.972	112.01	0.352	126.47	0.781
		±54.67		±54.07		±57.53		±55.03		±54.85
	AC	115.63		111.17		127.01		109.21		130.08
		±56.30		±60.15		±45.61		±60.38		±44.77
ATV (ml)	BC	174.62	0.048	174.27	0.060	175.58	0.485	174.53	0.075	174.83	0.260
		±198.28		±220.29		±127.79		±225.03		±121.45
	AC	119.40		103.58		163.33		104.85		154.30
		±87.88		±78.88		±101.16		±80.31		±99.56
RTV (ml/m²)	BC	107.86	0.059	109.32	0.074	103.83	0.463	109.49	0.092	103.96	0.241
		±119.18		±132.50		±76.87		±135.34		±72.47
	AC	75.47		67.95		96.35		68.88		91.28
		±51.20		±47.33		±58.53		±48.12		±57.47
ATA (mm)	BC	60.49	0.075	58.06	0.011	66.65	0.380	57.31	0.016	67.62	0.540
		±17.11		±18.56		±11.18		±18.47		±11.18
	AC	56.82		51.78		69.66		51.14		69.62
		±14.88		±12.96		±11.63		±12.74		±11.09
TAR	BC	0.89	0.114	0.89	0.009	0.87	0.260	0.85	0.018	0.96	0.670
		±0.29		±0.32		±0.17		±0.25		±0.35
	AC	0.84		0.80		0.94		0.77		0.99
		±0.26		±0.25		±0.25		±0.20		±0.30

Abbreviations: SD standard deviation, BC before neoadjuvant chemotherapy, AC after neoadjuvant chemotherapy, ATL absolute tumor length, ATV absolute tumor volume, RTV relative tumor volume, ATA absolute tumor axial size, TAR tumor axial ratio.

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com